BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02179671-completion@plaintrial.com
DTSTAMP:20261029T172605Z
DTSTART;VALUE=DATE:20160611
SUMMARY:Immune-Modulated Study of Selected Small Molecules (Gefitinib\, AZD
 9291\, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT\;
  Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patient
 s With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer — estim
 ated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02179671
URL:https://plaintrial.com/trial/NCT02179671
END:VEVENT
END:VCALENDAR